---
title: A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson’s Disease (BeyoND)
euct_id: 2024-513548-27-00
eudra_ct_number: 2015-005814-31
phase: Phase 4
status: Recruiting
sponsor: Neuroderm Ltd.
canonical_url: "https://parkinsonspathways.com/trials/eu/2024-513548-27-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2024-513548-27-00"
ctis_last_updated: "2025-10-24T03:32:05.015240428"
source: EU Clinical Trials Information System (CTIS)
---
# A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson’s Disease (BeyoND)

**EU CT Number:** [2024-513548-27-00](https://euclinicaltrials.eu/ctis-public/view/2024-513548-27-00)

## Key Facts

- **Phase:** Phase 4
- **Status:** Recruiting
- **Sponsor:** Neuroderm Ltd.
- **Start Date:** 2016-10-18
- **Completion Date:** 2027-05-23
- **Conditions:** Parkinson's disease
- **Interventions:** ND0612

## Member States

Trial is authorized in 4 member states: Austria, France, Italy, Poland.

## Sites (13)

- Medizinische Universitaet Innsbruck, Innsbruck, Austria
- Irccs San Raffaele Roma S.r.l., Rome, Italy
- Universita' Degli Studi G. D'annunzio Di Chieti, Chieti Scalo, Italy
- Krakowska Akademia Neurologii Sp. z o.o., Cracow, Poland
- Indywidualna Praktyka Lekarska prof. Konrad Rejdak, Lublin, Poland
- Centrum Medyczne Plejady Magdalena Celinska Loewenhoff Michal Zolnowski sp.k., Cracow, Poland
- Centre Hospitalier Universitaire De Lille, Lille Cedex, France
- Centre Hospitalier Universitaire Amiens Picardie, Amiens Cedex 1, France
- CHU Gabriel-Montpied, Clermont Ferrand, France
- Centre Hospitalier Universitaire De Poitiers, Poitiers, France
- Centre Hospitalier Regional De Marseille, Marseille, France
- Centre Hospitalier Du Pays D Aix Centre Hospitalier Intercommunal Aix-Pertuis, Aix En Provence, France
- Hospital Pierre Wertheimer, Bron, France

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's disease
Age groups: elderly 65+, adults 18-64
Sex: male, female
Includes a vulnerable population.
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2024-513548-27-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2024-513548-27-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2024-513548-27-00*